🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pivotal Phase 3 trial plans to enroll a total of approximately 12,460 p...
Status
Completed
Location
Jagiellońskie Centrum Innowacji Sp.z o.o.
Start Date
2018-08-01
Trial ID
NCT03450915
"Multimeric-001" (M-001) has been recently developed, containing conserved,...
Status
Completed
Location
Hadassah medical center
Start Date
2011-08
Trial ID
NCT01419925
Gaucher disease (GD) is caused by mutations in the GBA1 gene, which leads t...
Status
Recruiting
Location
Guangzhou First People's Hospital
Start Date
2024-07-05
Trial ID
NCT06818838
Treatments Being Tested
This is a multi-center, randomized, two stage, double-blind, placebo-contro...
Status
Completed
Location
Clinical Research Center, Hadassah Medical Center
Start Date
2010-07
Trial ID
NCT01146119
Treatments Being Tested
This is a prospective single-center, open, single-arm, single-dose intraven...
Status
Recruiting
Location
The First Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-11-15
Trial ID
NCT06162338
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability, efficac...
Status
Active Not Recruiting
Location
Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
Start Date
2024-08-01
Trial ID
NCT06528080
Treatments Being Tested
This is a single-site, randomized, double-blind, placebo-controlled study o...
Status
Completed
Location
Clinical Research Center, Tel-Aviv Sourasky Medical Center
Start Date
2014-11
Trial ID
NCT02293317
Aromatase inhibitors have been approved for use in postmenopausal women to ...
Status
Completed
Location
Jasper Research Clinic
Start Date
2007-03
Trial ID
NCT00467493
Treatments Being Tested
This is a Phase II randomized, double-blind, placebo-controlled trial in 12...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2018-04-09
Trial ID
NCT03058692
Treatments Being Tested
This is a phase I/II, randomized, single-blind, placebo-controlled escalati...
Status
Completed
Location
Tasmc Crc
Start Date
2009-09
Trial ID
NCT01010737